An Open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Sunitinib; Vinflunine
- Indications Cancer
- Focus Therapeutic Use
- Acronyms IMbrella A
- Sponsors Chugai Pharmaceutical; Roche
- 11 Apr 2018 Planned number of patients changed from 556 to 546.
- 19 Jan 2018 Status changed from not yet recruiting to recruiting.
- 24 Aug 2017 Planned initiation date changed from 5 Aug 2017 to 16 Sep 2017.